Deep Track Capital, LP 13D/13G Filings for Chinook Therapeutics, Inc. (KDNY)

Deep Track Capital, LP 13D and 13G filings for Chinook Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
08:42 am
Purchase		 2022-12-31 13G Chinook Therapeutics, Inc.
KDNY		 Deep Track Capital, LP 3,000,000
4.690%		 247,930increase
(+9.01%)		 Filing
2022-02-16
4:46 pm
Purchase		 2022-02-14 13G Chinook Therapeutics, Inc.
KDNY		 Deep Track Capital, LP 2,752,070
5.040%		 2,752,070increase
(New Position)		 Filing